Abstract
Serum TSH levels, determined by a very sensitive immunofluorescent assay, were found to be consistently higher in euthyroid individuals with thyroid cancer than in normal persons or those with other thyroid diseases or with non-thyroidal cancers. Thyroid cancer patients required larger thyroxin doses for TSH suppression than controls. From these studies it appears that chronic TSH stimulation, long known to produce thyroid cancer in experimental animals, may also play a causative role in human thyroid cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
